Results 61 to 70 of about 11,519,201 (265)

Minutes: Medical School Faculty Assembly, May 8, 2003

open access: yes, 2003
University of Minnesota. Medical School Faculty Assembly. (2003). Minutes: Medical School Faculty Assembly, May 8, 2003.
University of Minnesota. Medical School Faculty Assembly
core  

Erciyes University Medical Faculty Lecturers' Opinions about Undergraduate Medical Education [PDF]

open access: yes, 2018
Objective: The aim is to exhibit the opinions of medical members in Erciyes University Medical Faculty on undergraduate medical education and take their views on improving the ...
BAYKAN, Zeynep   +6 more
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Minutes: Medical School Faculty Assembly, November 17, 2008

open access: yes, 2008
University of Minnesota. Medical School Faculty Assembly. (2008). Minutes: Medical School Faculty Assembly, November 17, 2008.
University of Minnesota. Medical School Faculty Assembly
core  

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Minutes: Medical School Faculty Assembly, October 16, 2006

open access: yes, 2006
University of Minnesota. Medical School Faculty Assembly. (2006). Minutes: Medical School Faculty Assembly, October 16, 2006.
University of Minnesota. Medical School Faculty Assembly
core  

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

New tools for systematic evaluation of teaching qualities of medical faculty: results of an ongoing multi-center survey.

open access: yesPLoS ONE, 2011
BackgroundTools for the evaluation, improvement and promotion of the teaching excellence of faculty remain elusive in residency settings. This study investigates (i) the reliability and validity of the data yielded by using two new instruments for ...
Onyebuchi A Arah   +3 more
doaj   +1 more source

Minutes: Medical School Faculty Assembly, December 1, 2009

open access: yes, 2009
University of Minnesota. Medical School Faculty Assembly. (2009). Minutes: Medical School Faculty Assembly, December 1, 2009.
University of Minnesota. Medical School Faculty Assembly
core  

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy